PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 7 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
BRIEF published on 02/28/2024 at 07:30, 2 years 7 months ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years 7 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 7 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
PRESS RELEASE published on 09/28/2023 at 10:30, 3 years ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 3 years ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 3 years ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 3 years 1 month ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 3 years 3 months ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 3 years 3 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
Published on 10/07/2026 at 01:45, 5 hours 15 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 5 hours 30 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 5 hours 55 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 7 hours 15 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 7 hours 28 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/07/2026 at 06:30, 30 minutes ago Global Youth Powerhouse Summit 2026 Concludes Successfully
Published on 10/06/2026 at 19:05, 11 hours 55 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 12 hours 30 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 12 hours 55 minutes ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 13 hours ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 19:15, 11 hours 45 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 11 hours 45 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 12 hours 21 minutes ago Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 12 hours 21 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 12 hours 45 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
